N4 Pharma Plc (N4P.L)
GBp 0.53
(-8.7%)
GBp 0.53
(-8.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.2 Million | -828.26 Thousand | -1.77 Million | -1.37 Million | -806 Thousand | -1.34 Million |
| Net Income | -1.26 Million | -1.02 Million | -1.54 Million | -1.56 Million | -948.72 Thousand | -1.39 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3431.00 | 23.99 Thousand | 16.66 Thousand | 3977.00 | 3767.00 | 629.00 |
| Change in working capital | 48.06 Thousand | -172.15 Thousand | 54.39 Thousand | 60.86 Thousand | -82.99 Thousand | 1639.00 |
| Other non-cash items | -32.06 Thousand | 349.15 Thousand | -298.94 Thousand | 122.47 Thousand | 221.95 Thousand | 43.86 Thousand |
| Investing Cash Flow | 781.00 | - | - | - | - | 27.69 Thousand |
| Investments in PPE | -2.00 | - | - | - | - | - |
| Acquisitions | 781.00 | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 27.69 Thousand |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 315.9 Thousand | 963.76 Thousand | 677.00 | 3.96 Million | 978.61 Thousand | 783.42 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 315.9 Thousand | 1.05 Million | - | 3.97 Million | 980 Thousand | 784.4 Thousand |
| Other Financing Activities | -34.1 Thousand | -90.23 Thousand | 677.00 | -1963.00 | -1385.00 | -981.00 |
| Accounts receivables | 44.23 Thousand | -37.31 Thousand | 10.74 Thousand | -30.53 Thousand | 29.44 Thousand | -9266.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3838.00 | -134.84 Thousand | 43.64 Thousand | 91.39 Thousand | -112.44 Thousand | 10.9 Thousand |
| Cash at beginning of period | 1.91 Million | 1.78 Million | 3.55 Million | 965.75 Thousand | 793.14 Thousand | 1.32 Million |
| Cash at end of period | 1.02 Million | 1.91 Million | 1.78 Million | 3.55 Million | 965.75 Thousand | 793.14 Thousand |
| Capital Expenditure | -2.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -892.41 Thousand | 135.5 Thousand | -1.77 Million | 2.58 Million | 172.61 Thousand | -533.13 Thousand |
| Free Cash Flow | -1.2 Million | -828.26 Thousand | -1.77 Million | -1.37 Million | -806 Thousand | -1.34 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -454.86 Thousand | -623.18 Thousand | -1.26 Million | -646.15 Thousand | -1.02 Million | -279.15 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 3431.00 | - | 23.99 Thousand | - |
| Change in working capital | 92.33 Thousand | 35.1 Thousand | 48.06 Thousand | 12.95 Thousand | -172.15 Thousand | -710.74 Thousand |
| Other non-cash items | -28.34 Thousand | 330.00 | -32.06 Thousand | -32.39 Thousand | 349.15 Thousand | 932.92 Thousand |
| Investing Cash Flow | - | 781.00 | 781.00 | - | - | - |
| Investments in PPE | -1.00 | 2.00 | - | - | - | - |
| Acquisitions | - | 781.00 | 781.00 | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 568.7 Thousand | 317.14 Thousand | 315.9 Thousand | -1244.00 | 963.76 Thousand | 964.43 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 570.36 Thousand | 315.9 Thousand | 315.9 Thousand | - | 1.05 Million | 963.76 Thousand |
| Other Financing Activities | -1657.00 | 1244.00 | - | -1244.00 | -90.23 Thousand | 667.00 |
| Accounts receivables | 118.02 Thousand | 7160.00 | 44.23 Thousand | 37.07 Thousand | -37.31 Thousand | -567.86 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -25.68 Thousand | 27.94 Thousand | 3838.00 | -24.11 Thousand | -134.84 Thousand | -142.88 Thousand |
| Cash at beginning of period | 1.02 Million | 1.28 Million | 1.91 Million | 1.91 Million | 1.78 Million | 1.57 Million |
| Cash at end of period | 1.2 Million | 1.02 Million | 1.02 Million | 1.28 Million | 1.91 Million | 1.91 Million |
| Capital Expenditure | -1.00 | 2.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 177.83 Thousand | -262.65 Thousand | -892.41 Thousand | -629.76 Thousand | 135.5 Thousand | 339.58 Thousand |
| Free Cash Flow | -390.87 Thousand | -580.58 Thousand | -1.2 Million | -628.51 Thousand | -828.26 Thousand | -624.85 Thousand |
BLACKROSE
001896
002148
STCK
AQUA
600644